Celebrated annually on March 8th, International Women’s Day is a global day of recognition to celebrate the achievements of women and to call for equality and the advancement of women worldwide. KCR is proud to uplift the voices and achievements of women across the globe, especially here, where they make…

KCR Chief Medical Officer, Dr. Anna Baran Q: What are the challenges in implementing bladder cancer studies? A: “Although bladder cancer (BC) has a poor prognosis and is the 10th most commonly diagnosed cancer and the 7th most diagnosed in the male population worldwide, implementing clinical trials in this indication…

Dr. Anna Baran, KCR Chief Medical Officer Rare Disease Day is a globally coordinated movement to shed light on rare diseases, to commit to working towards health equity, and to enhance access to diagnosis and therapies for people living with a rare disease.[1] The role the pharmaceutical industry plays in…

KCR Chief Technology Officer, Doug Bain, joined a panel of technology experts on Thursday’s ACDM Hot Topic Panel. The focus of this panel was the question, “What’s next for EDC?” In addition to KCR, the panel included voices from vendors and Sponsors who covered a variety of topics in the…

KCR experts are always on the lookout for top trends, but a new calendar year brings a lot of new opportunity. KCR thought leaders are surveying their sectors and weighing in on what they expect from the clinical research industry in 2023.

Doug Bain, Chief Technology Officer at KCR In Part 1, I described the architectural capabilities that define a clinical research cloud platform. In part 2, I am going to propose the functional capabilities (aka modules) that a platform should support in order to be considered a clinical research environment suitable…

Torsten Staller, KCR Director of Regulatory Affairs While the research-based pharmaceutical industry is pushing ahead with ongoing clinical trials (CT), the approaching deadline of 31 January 2023, when all first clinical trials must be entered into the Clinical Trials Information System (CTIS), is making some sweat. Many professionals have attended…

Piotr Blonski, Chief Financial Officer at KCR It is another great year for the JP Morgan healthcare conference. As always, it was great platform to exchange knowledge, thoughts and get a refreshed look at the industry. Here are my main takeaways from the week: Companies with strong balance sheets and…

Doug Bain, Chief Technology Officer at KCR Through a series of blogs posted over the last 3 years, I have highlighted the need for and value of cloud clinical research platforms. Put simply, a complete end-to-end digital clinical research platform will allow Sponsors/CRO’s, Sites and Patients to run efficient and…